Yuanxuan Cai | Healthcare Data Analysis | Best Researcher Award

Published on by Research Data Analysis

Ms. Yuanxuan Cai | Healthcare Data Analysis | Best Researcher Award

Ms. Yuanxuan Cai | Healthcare Data Analysis Huazhong University of Science and Technology | China

Ms. Yuanxuan Cai is a dedicated doctoral candidate in Pharmacy at Huazhong University of Science and Technology, with a strong academic background in pharmacoepidemiology and drug safety. Her research focuses on adverse drug event (ADE) risk assessment, pediatric pharmacovigilance, and neural network-based drug safety models. Yuanxuan has co-authored several peer-reviewed publications and contributed to multiple national and provincial research projects. She is highly skilled in data analysis, coding, and drug safety evaluation. With a passion for mental health and healthcare policy, she aims to improve public health outcomes through data-driven decision-making in clinical pharmacology and post-marketing drug surveillance.

Professional Profile

SCOPUS

Education 

Yuanxuan Cai is currently pursuing her Ph.D. in Pharmacy at Huazhong University of Science and Technology, Her coursework includes health policy, hospital management, and metrology analysis. She earned her Bachelor of Science in Pharmacy from the same university completing courses in medical statistics, pharmacology, and pharmaceutics. Throughout her academic journey, she has consistently demonstrated excellence in both theoretical and applied pharmaceutical sciences, receiving multiple scholarships and recognitions. Her educational background equips her with a strong foundation for advanced research in clinical drug safety and public health policy.

Professional Experience 

Ms. Cai has extensive experience participating in multiple high-impact research projects supported by the National Natural Science Foundation of China (NSFC) and provincial programs. Her work includes designing project frameworks, managing large-scale ADE data, performing signal detection using Python and SQL, and applying neural network models to evaluate drug safety. She has played key roles in studies on pediatric medications, oxaliplatin toxicity, and cephalosporin use in children. Yuanxuan is proficient in real-world data analysis, database management, and pharmacovigilance system development. Her hands-on experience with interdisciplinary teams reflects a commitment to improving healthcare safety through evidence-based approaches.

Awards and Recognition 

Yuanxuan Cai has received numerous accolades for her academic excellence and research contributions. These include the prestigious National Postgraduate Scholarship (2021), a continuous Postgraduate Academic Scholarship (2020–2024), and the Merit Student Award (2021). She also secured the 3rd Prize in the “Outstanding Knowledge and Action” competition and the 2nd Prize in the Qiaokou Innovation Scholarship (2022). As an undergraduate, she was honored with the Science and Technology Innovation Scholarship twice and was named an Outstanding Graduate in 2022. These recognitions highlight her commitment to academic rigor, innovation, and impactful research in pharmaceutical sciences.

Research Skills 

Yuanxuan Cai is proficient in advanced research methodologies, particularly in pharmacoepidemiology and big data analysis. She has hands-on experience with data cleaning and signal detection in ADE databases using Python and SQL. Her skill set includes constructing neural network models and applying logistic regression for predictive drug safety assessments. She has effectively used social network analysis and the Delphi method in pharmacovigilance research. Her coding proficiency extends to R for statistical analysis. Yuanxuan’s interdisciplinary expertise enables her to manage large datasets, evaluate drug combinations, and contribute meaningfully to clinical safety decision-making and public health improvement.

Publications

Suspected Adverse Drug Reactions Related to Statins: Analysis of Spontaneous Reports in Hubei Province, China (2014–2022)

  • Authors: Wang H, Bi H, Shangguan X, Chen Z, Huang R, Chen X, Cai Y*

  • Journal: Expert Opinion on Drug Safety

  • Year: 2025 (Accepted)

Predictive Model of Oxaliplatin-induced Liver Injury Based on Artificial Neural Network and Logistic Regression

  • Authors: Huang R, Cai Y, He Y, Yu Z, Zhao L, Wang T, et al.

  • Journal: Journal of Clinical and Translational Hepatology

  • Year: 2023

Risk Factors for Oxaliplatin-induced Hypersensitivity Reaction in Patients with Colorectal Cancer

  • Authors: Song Q, Cai Y, Guo K, Li M, Yu Z, Tai Q, et al.

  • Journal: American Journal of Translational Research

  • Year: 2022

Status and Safety Signals of Cephalosporins in Children: A Spontaneous Reporting Database Study

  • Authors: Cai Y, Yang L, Shangguan X, Zhao Y, Huang R

  • Journal: Frontiers in Pharmacology

  • Year: 2021

Safety of Traditional Chinese Medicine Injection Based on Spontaneous Reporting System from 2014 to 2019 in Hubei Province, China

  • Authors: Huang R, Cai Y, Yang L, Shangguan X, Ghose B, Tang S

  • Journal: Scientific Reports

  • Year: 2021

Rama Bhadekar – Healthcare Data Analysis – Women Researcher Award 

Published on by Research Data Analysis

Dr. Rama Bhadekar - Healthcare Data Analysis  - Women Researcher Award 

Bharati Vidyapeeth Deemed To Be University - india

Author Profile

Early Academic Pursuits

Dr. Mrs. Rama Bhadekar, formerly Neeta Kulkarni, embarked on her academic journey with a strong foundation in microbiology. Her educational qualifications include a PhD in Microbiology from the esteemed National Chemical Laboratory, Pune, completed in 1999. Prior to her doctoral studies, she excelled in her undergraduate and postgraduate studies, securing First Class honors in both BSc and MSc Microbiology from the University of Pune.

Professional Endeavors

With over two decades of experience in academia and research, Dr. Bhadekar has made significant contributions to her field. She started her career in the biotech industry as a consultant before transitioning to academia. She served as a lecturer at Modern College, Ganeshkhind, Pune, from 2002 to 2004, before joining the Rajiv Gandhi Institute of IT and Biotechnology (RGITBT), Bharati Vidyapeeth (deemed to be) University (BVDU), Pune, where she has been associated since 2004.

Contributions and Research Focus On Healthcare Data Analysis

Dr. Bhadekar's research focuses on microbial biotechnology, particularly in areas related to PUFA synthesis, omega-3 fatty acid production, and biocontrol agents. Her work has been funded by prestigious organizations like the Department of Science and Technology (DST) and the Department of Biotechnology (DBT), showcasing the relevance and impact of her research in addressing crucial scientific challenges.

Accolades and Recognition

Throughout her career, Dr. Bhadekar has garnered recognition for her scholarly achievements. Notably, she received the Young Scientist Award in 2024, acknowledging her outstanding contributions to gender studies.

Impact and Influence

Dr. Bhadekar's research has left a significant impact on the scientific community, evident from her extensive publication record in renowned international journals, book chapters, and conference proceedings. Her collaborative efforts with national and international institutions have further enriched her research endeavors, contributing to the advancement of microbiology and biotechnology.

Legacy and Future Contributions

As an educator, researcher, and academic leader, Dr. Bhadekar's legacy extends beyond her individual achievements. Her mentorship of Ph.D. students, involvement in institutional quality assurance, and active participation in academic and professional societies underscore her commitment to nurturing the next generation of scientists. With a relentless pursuit of excellence, Dr. Bhadekar continues to push the boundaries of scientific knowledge, shaping the future of microbial biotechnology and inspiring generations to come.

Citations

  • Citations   583
  • h-index       10
  • i10-index    10

Notable Publication